Astaxanthin in APAC: Israeli biotech firm invests in Kiwi manufacturer to boost regional sales By Cheryl Tay 04-May-2018 - Last updated on 04-May-2018 at 01:32 GMT Facebook Twitter Linkedin Email to a friend Israeli biotechnology firm Algatechnologies (Algatech) is now the major shareholder in Kiwi astaxanthin manufacturer Supreme Health, with both companies sharing the goal of expanding further in China, as well as the wider Asia Pacific market.Read the full story here. April's top 10 stories WATCH: Three myths to bust about supplements — Blackmores Institute Nature's Care sale: Chinese private equity firms take majority stake in Aussie supplement brand China cross-border e-commerce access: 'Too early to say what will happen in 2019' – trade expert Two New Zealand industry pioneers step down from leading roles at trade body Danone RCT: Synbiotic mixture improves microbiota in toddlers – Thai trial Herbal supplements in Indonesia: On-trend ingredients and pressing health concerns revealed 'NZ has to keep punching above its weight': New contract manufacturer GM eyes 'huge global opportunities' Healthy Ageing APAC Summit: Experts from Japan to shine the spotlight on nutrition and food opportunities Astaxanthin in APAC: Israeli biotech firm invests in Kiwi manufacturer to boost regional sales Is the Chinese state poised to redress the balance between international and domestic formula brands? Prev 1 … 7 8 9 10 11 Next